Recent clinical trends in Toll-like receptor targeting therapeutics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent clinical trends in Toll-like receptor targeting therapeutics
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-19
DOI
10.1002/med.21553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- (2018) Lan Huang et al. Cellular & Molecular Immunology
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study
- (2018) Philip E. Silkoff et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
- (2018) Harry L.A. Janssen et al. JOURNAL OF HEPATOLOGY
- The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
- (2018) Md Jakir Hossain et al. Frontiers in Immunology
- Toll-like receptors in COPD
- (2017) Philip M. Hansbro et al. EUROPEAN RESPIRATORY JOURNAL
- Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities
- (2017) Lei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-molecule inhibition of TLR8 through stabilization of its resting state
- (2017) Shuting Zhang et al. Nature Chemical Biology
- Airway Mucin Concentration as a Marker of Chronic Bronchitis
- (2017) Mehmet Kesimer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
- (2017) V Mett et al. ONCOGENE
- Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation
- (2017) Ilia A. Toshkov et al. RADIATION RESEARCH
- Why clinical trial outcomes fail to translate into benefits for patients
- (2017) Carl Heneghan et al. Trials
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- A conserved TLR5 binding and activation hot spot on flagellin
- (2017) Wan Seok Song et al. Scientific Reports
- Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
- (2016) Patrick Vianna Garcia et al. BMC CANCER
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
- (2016) Bradley J. Monk et al. CLINICAL CANCER RESEARCH
- Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS
- (2016) E Monnet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Osteoimmunology and Beyond
- (2016) Lia Ginaldi et al. CURRENT MEDICINAL CHEMISTRY
- TLR7 Structure: Cut in Z-Loop
- (2016) Kazuhiko Maeda et al. IMMUNITY
- Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA
- (2016) Zhikuan Zhang et al. IMMUNITY
- Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
- (2016) Keith Biggadike et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
- (2016) Leo A. B. Joosten et al. Nature Reviews Rheumatology
- Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8
- (2016) Hiromi Tanji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS
- (2016) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
- (2016) Thomas J. Hwang et al. JAMA Internal Medicine
- Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants
- (2016) Anna Pomerenke et al. International Journal of Chronic Obstructive Pulmonary Disease
- CYT003, a TLR9 agonist, in persistent allergic asthma - a randomized placebo-controlled Phase 2b study
- (2015) T. B. Casale et al. ALLERGY
- Toll-Like Receptor 2 (TLR2) and TLR9 Play Opposing Roles in Host Innate Immunity against Salmonella enterica Serovar Typhimurium Infection
- (2015) Renhui Zhan et al. INFECTION AND IMMUNITY
- Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
- (2015) Umeharu Ohto et al. NATURE
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
- (2015) Cristiano Xavier Lima et al. PLoS One
- Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
- (2015) Mark W. Julian et al. PLoS One
- Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation
- (2015) Wei Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics
- (2015) Elisabetta Pace et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines
- (2015) M. Karlsen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor 8 senses degradation products of single-stranded RNA
- (2015) Hiromi Tanji et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
- (2015) Hua Yang et al. Oncotarget
- Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
- (2015) Manh-Cuong Vo et al. Oncotarget
- The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development
- (2015) Hong Zheng et al. Scientific Reports
- Dendritic cell targeted vaccines: Recent progresses and challenges
- (2015) Pengfei Chen et al. Human Vaccines & Immunotherapeutics
- Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+T cells from allergic patients
- (2014) S. Deifl et al. ALLERGY
- TLRs: Linking inflammation and breast cancer
- (2014) Khyati Bhatelia et al. CELLULAR SIGNALLING
- Mycobacterium indicus praniiandMycobacterium bovisBCG lead to differential macrophage activation in Toll-like receptor-dependent manner
- (2014) Pawan Kumar et al. IMMUNOLOGY
- Safety of Toll-like receptor 9 agonists: a systematic review and meta-analysis
- (2014) Mei Qin et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- TLR Cross-talk Confers Specificity to Innate Immunity
- (2014) Rebecca S. T. Tan et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- (2014) A. Ruzsa et al. INVESTIGATIONAL NEW DRUGS
- Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
- (2014) Liliana Schaefer JOURNAL OF BIOLOGICAL CHEMISTRY
- Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease
- (2014) C. J. Blohmke et al. JOURNAL OF IMMUNOLOGY
- Imiquimod is not an effective drug for molluscum contagiosum
- (2014) Kenneth A Katz LANCET INFECTIOUS DISEASES
- Role of TLR5 and Flagella in Bacillus Intraocular Infection
- (2014) Salai Madhumathi Parkunan et al. PLoS One
- Human TLR10 is an anti-inflammatory pattern-recognition receptor
- (2014) Marije Oosting et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
- (2014) Nan Wang et al. Frontiers in Immunology
- Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension
- (2013) Cameron G. McCarthy et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Second Messenger Phosphatidylinositol-5-Phosphate Facilitates Antiviral Innate Immune Signaling
- (2013) Takumi Kawasaki et al. Cell Host & Microbe
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structure and dynamic behavior of Toll-like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols ofPlasmodium falciparum
- (2013) Prasannavenkatesh Durai et al. FEBS Journal
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells
- (2013) I. Ioannidis et al. JOURNAL OF VIROLOGY
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle
- (2013) Pervaiz Dar et al. VACCINE
- Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
- (2013) Athina Savva et al. Frontiers in Immunology
- DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
- (2013) Traci L Hilton et al. Journal for ImmunoTherapy of Cancer
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
- (2012) Fatih Arslan et al. Circulation-Cardiovascular Interventions
- The Effects of TLR Activation on T-Cell Development and Differentiation
- (2012) Bo Jin et al. Clinical & Developmental Immunology
- Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
- (2012) Yi-Tzu Lin et al. CURRENT GENOMICS
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
- (2012) Greg S Martin Expert Review of Anti-Infective Therapy
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Regulation of B-cell responses by Toll-like receptors
- (2012) Edward P. Browne IMMUNOLOGY
- TLR3 activation efficiency by high or low molecular mass poly I:C
- (2012) Yu Zhou et al. Innate Immunity
- IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis
- (2012) Christophe Cataisson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
- (2012) Mauricio A. Arias et al. PLoS One
- Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics
- (2011) Jean-Laurent Casanova et al. Annual Review of Immunology
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection
- (2011) Christopher D. Romero et al. INFECTION AND IMMUNITY
- Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface
- (2011) V. Y. Toshchakov et al. JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Small-Molecule Inhibitors of the TLR3/dsRNA Complex
- (2011) Kui Cheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Direct, Noncatalytic Mechanism of IKK Inhibition by A20
- (2011) Brian Skaug et al. MOLECULAR CELL
- The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
- (2011) Jae-Min Yuk et al. NATURE IMMUNOLOGY
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate
- (2011) Natarajan Muthusamy et al. Cancer Genetics
- Similar Structures but Different Roles – An Updated Perspective on TLR Structures
- (2011) Balachandran Manavalan et al. Frontiers in Physiology
- DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
- (2010) Nga N. Ta et al. ATHEROSCLEROSIS
- When failure should be the option
- (2010) Gregory A Petsko BMC BIOLOGY
- Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro
- (2010) Rachel A. Bunting et al. CELLULAR IMMUNOLOGY
- Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
- (2010) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Flagellin as an Adjuvant: Cellular Mechanisms and Potential
- (2010) S. B. Mizel et al. JOURNAL OF IMMUNOLOGY
- TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus
- (2010) Kevin M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
- (2010) Su-Chang Lin et al. NATURE
- Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b
- (2010) Chaofeng Han et al. NATURE IMMUNOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
- (2009) Matthijs Kox et al. BIOCHEMICAL PHARMACOLOGY
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria
- (2009) P. Gross et al. INFECTION AND IMMUNITY
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
- (2009) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice
- (2009) Marie-Laure Santiago-Raber et al. JOURNAL OF AUTOIMMUNITY
- TLR Cross-Talk Specifically Regulates Cytokine Production by B Cells from Chronic Inflammatory Disease Patients
- (2009) M. Jagannathan et al. JOURNAL OF IMMUNOLOGY
- Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells
- (2009) S. M. Makela et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88–independent TLR4 pathway
- (2009) Eva M Palsson-McDermott et al. NATURE IMMUNOLOGY
- TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
- (2008) M MATSUMOTO et al. ADVANCED DRUG DELIVERY REVIEWS
- Protective Role of Toll-like Receptor 4 during the Initiation Stage of Cutaneous Chemical Carcinogenesis
- (2008) N. Yusuf et al. CANCER RESEARCH
- A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands
- (2008) David Dowling et al. CYTOKINE
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
- (2008) Ulrich Zähringer et al. IMMUNOBIOLOGY
- Toll-Like Receptor 9-Dependent Immune Activation by Unmethylated CpG Motifs in Aspergillus fumigatus DNA
- (2008) Z. G. Ramirez-Ortiz et al. INFECTION AND IMMUNITY
- TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation
- (2008) Mude Shi et al. NATURE IMMUNOLOGY
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
- (2008) Jonathan C Kagan et al. NATURE IMMUNOLOGY
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now